Moderate riskFDA DrugClass II

Advanced Pharmaceutical Technology TESTO-100 testosterone pellets recalled for potential microbial contamination

Advanced Pharmaceutical Technology is recalling TESTO-100 CIII testosterone pellets (Lot P-22-3, expiration 06-2027) because they may not be sterile and could be contaminated with harmful microbes. These are prescription implant pellets used for testosterone replacement therapy. The recall affects 22,843 pellets distributed in Georgia, New York, Texas, Puerto Rico, the United Kingdom, Malta, and Greece.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have received TESTO-100 pellets from Lot P-22-3, contact your doctor or pharmacist immediately.
  2. Do not use the pellets unless your healthcare provider confirms they are safe.
  3. Ask your provider about safe alternatives or next steps for your treatment.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
Sold in
GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece
Made for
Adults (0 months and older)

Details

Units affected
22,843 pellets
Illnesses reported
None reported
Manufactured in
132 S Central Ave, Elmsford, NY, United States
Classification
Class II
Recall number
D-0258-2026

In the FDA's words

Description
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01 Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets. Lot #: P-22-3, Exp 06-2027 Distribution: GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece Affected quantity: 22,843 pellets
Hazard
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

Related topics